Lynn Miesel

Biography

Lynn Miesel is the Global Anti-Infectives Director and collaborates with Business Development and Operations to conduct efficacy studies for our international infectious disease clients. She applies more than 13 years of industry experience in anti-infectives to lead projects that use in vitro and in vivo microbiology assays to assess the efficacy of novel antibacterial and antifungal agents. Dr. Miesel's supervisory and leadership experience in the pharmaceutical industry includes expertise in genetics, biochemistry, microbiology, pharmacology, and infectious diseases drug discovery. She has extensive experience in project design and leadership, including international external collaborations. Prior to her role with Eurofins, Dr. Miesel worked for the Merck Research Laboratories as the Biology Collaboration Lead for infectious disease research. While there, she designed and managed projects for target validation, screening, lead identification and lead optimization programs for antimicrobial and antiviral programs. Dr. Miesel served on Merck's anti-infectives licensing review committee and currently serves as an ad hoc grant reviewer for the National Institutes of Health. She has coauthored sixteen peer-reviewed publications and over twenty meeting abstracts.

Research Interest

Pharmaceutical Sciences